User login
For the September podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses 3 Original Reports: one on identifying the risk factors for hospital readmission among patients who have received a hematopoietic stem cell transplant and designing preventive measures to lower those risks and related readmissions; a second that focuses on young women with breast cancer who are from diverse populations and who face specific challenges in regard to their existing support systems and unmet needs for information and support; and the third that examines the effects of a self-care education program on the quality of life of in patients with gastric cancer after they have undergone gastrectomy. Dr Henry also highlights this month’s Community Translations article on the approval of nivolumab, the first immunotherapy to receive the go-ahead from the Food and Drug Administration for the treatment of for lung cancer, specifically, squamous cell non-small-cell lung cancer, and an accompanying Commentary by Dr Kartik Konduri. The podcast is rounded off with comments on an essay about the shift from practicing oncology as a generalist to the current more prevalent tendency to subspecialize, and an argument suggesting that the generalist approach offers a potentially useful perspective to help make sense of what can seem like an overwhelming amount of data on emerging new therapies and understanding of tumor biology.
Click on the download icon at the top of this introduction to listen to the podcast.
For the September podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses 3 Original Reports: one on identifying the risk factors for hospital readmission among patients who have received a hematopoietic stem cell transplant and designing preventive measures to lower those risks and related readmissions; a second that focuses on young women with breast cancer who are from diverse populations and who face specific challenges in regard to their existing support systems and unmet needs for information and support; and the third that examines the effects of a self-care education program on the quality of life of in patients with gastric cancer after they have undergone gastrectomy. Dr Henry also highlights this month’s Community Translations article on the approval of nivolumab, the first immunotherapy to receive the go-ahead from the Food and Drug Administration for the treatment of for lung cancer, specifically, squamous cell non-small-cell lung cancer, and an accompanying Commentary by Dr Kartik Konduri. The podcast is rounded off with comments on an essay about the shift from practicing oncology as a generalist to the current more prevalent tendency to subspecialize, and an argument suggesting that the generalist approach offers a potentially useful perspective to help make sense of what can seem like an overwhelming amount of data on emerging new therapies and understanding of tumor biology.
Click on the download icon at the top of this introduction to listen to the podcast.
For the September podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses 3 Original Reports: one on identifying the risk factors for hospital readmission among patients who have received a hematopoietic stem cell transplant and designing preventive measures to lower those risks and related readmissions; a second that focuses on young women with breast cancer who are from diverse populations and who face specific challenges in regard to their existing support systems and unmet needs for information and support; and the third that examines the effects of a self-care education program on the quality of life of in patients with gastric cancer after they have undergone gastrectomy. Dr Henry also highlights this month’s Community Translations article on the approval of nivolumab, the first immunotherapy to receive the go-ahead from the Food and Drug Administration for the treatment of for lung cancer, specifically, squamous cell non-small-cell lung cancer, and an accompanying Commentary by Dr Kartik Konduri. The podcast is rounded off with comments on an essay about the shift from practicing oncology as a generalist to the current more prevalent tendency to subspecialize, and an argument suggesting that the generalist approach offers a potentially useful perspective to help make sense of what can seem like an overwhelming amount of data on emerging new therapies and understanding of tumor biology.
Click on the download icon at the top of this introduction to listen to the podcast.